BILL · 2025–26 SESSION

HB 2176: Drug therapy agreements/PRA

Exempting information in collaborative drug therapy agreements from disclosure under the public records act.

Summary

  • Prohibits the disclosure of a Collaborative Drug Therapy Agreement, including any attachments or appendices to the agreement, except in circumstances involving disciplinary actions against certain licensed health professionals.

From the House Bill Report (HB 2176), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · stalled on the House floor
  1. IntroducedJan 12, 2026
  2. Out of committeeFeb 2, 2026
  3. Passed Housestopped here
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
My-Linh Thai (D-41)
Introduced
January 12, 2026 in the House
Last action
February 19, 2026

AN ACT Relating to exempting information in collaborative drug therapy agreements from disclosure under the public records act;

Sponsors

Votes

No recorded floor votes.

History

  1. Returned to Rules Committee for second reading.
  2. House Rules "X" file.
  3. Rules Committee relieved of further consideration. Placed on second reading.
  4. Referred to Rules 2 Review.
  5. Minority; without recommendation.
  6. Minority; do not pass.
  7. SGOV - Majority; do pass.
  8. SGOV - Executive action taken by committee.
  9. First reading, referred to State Government & Tribal Relations.
  10. Prefiled for introduction.

HB 2176 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page